EUVIMEDEUVIMED entdecken
Multizentrische Studie

Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy

F Poumeaud, T Valentin, N Fares, B Segier, S Watson, B Verret, C Tlemsani, N Penel, S Lejeune, N Firmin, A Sabouret, J-C Thery und 26 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2024.115196 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von F Poumeaud und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Department of Digestive Medical Oncology, Toulouse University Hospital, T…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Sarcoma, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal Neoplasms, Hereditary NonpolyposisSarcomaImmunotherapyImmune Checkpoint InhibitorsHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedFranceDNA Mismatch RepairMutS Homolog 2 ProteinYoung AdultMicrosatellite InstabilityAged, 80 and over

Stichwörter der Autor:innen

Deficient mismatch repairImmune checkpoint inhibitorsLynch SyndromeMSH2Microsatellite instabilityPleomorphic rhabdomyosarcomas

Substanzen

MutS Homolog 2 ProteinMSH2 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.
  • Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.
  • Department of Digestive Medical Oncology, Toulouse University Hospital, Toulouse, France; Toulouse Cancer Research Centre, Toulouse, France.
  • Biostatistics & Health Date Science Unit, Oncopole Claudius Regaud IUCT-O, Toulouse, France.
  • Department of Medical Oncology, Institut Curie, Paris, France.
  • Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

Zitieren

APA

Poumeaud, F., Valentin, T., Fares, N., Segier, B., Watson, S., Verret, B., Tlemsani, C., Penel, N., Lejeune, S., Firmin, N., Sabouret, A., Thery, J. C., Bonvalot, S., Cottereau, E., Cauchin, E., Lancon, A., Nambot, S., Zattara, H., Coudert, M., …, & Guimbaud, R. (2025). Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115196

Vancouver

Poumeaud F, Valentin T, Fares N, Segier B, Watson S, Verret B, et al. Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115196

BibTeX
@article{Poumeaud2025,
  author = {Poumeaud, F and Valentin, T and Fares, N and Segier, B and Watson, S and Verret, B and Tlemsani, C and Penel, N and Lejeune, S and Firmin, N and Sabouret, A and Thery, J-C and Bonvalot, S and Cottereau, E and Cauchin, E and Lancon, A and Nambot, S and Zattara, H and Coudert, M and Fourme, E and Nogues, C and Tougeron, D and Prieur, F and Collonge-Rame, M-A and Denis, C and Laurent-Puig, P and Chieze-Valero, S and Dreyfus, H and Jaffrelot, M and Vande Perre, P and Rochaix, P and Gomez-Mascard, A and Rochefort, P and Campoy, S and Chibon, F and Lasset, C and Selves, J and Guimbaud, R},
  title = {Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2024.115196}
}
Kostenlos starten →